194 related articles for article (PubMed ID: 24644285)
1. Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma.
Qin Y; Fu M; Takahashi M; Iwanami A; Kuga D; Rao RG; Sudhakar D; Huang T; Kiyohara M; Torres K; Dillard C; Inagaki A; Kasahara N; Goodglick L; Braun J; Mischel PS; Gordon LK; Wadehra M
J Biol Chem; 2014 May; 289(20):13974-85. PubMed ID: 24644285
[TBL] [Abstract][Full Text] [Related]
2. Epithelial membrane protein-2 (EMP2) promotes angiogenesis in glioblastoma multiforme.
Qin Y; Takahashi M; Sheets K; Soto H; Tsui J; Pelargos P; Antonios JP; Kasahara N; Yang I; Prins RM; Braun J; Gordon LK; Wadehra M
J Neurooncol; 2017 Aug; 134(1):29-40. PubMed ID: 28597184
[TBL] [Abstract][Full Text] [Related]
3. Epithelial membrane protein-2 promotes endometrial tumor formation through activation of FAK and Src.
Fu M; Rao R; Sudhakar D; Hogue CP; Rutta Z; Morales S; Gordon LK; Braun J; Goodglick L; Wadehra M
PLoS One; 2011; 6(5):e19945. PubMed ID: 21637765
[TBL] [Abstract][Full Text] [Related]
4. FAK activation and the role of epithelial membrane protein 2 (EMP2) in collagen gel contraction.
Morales SA; Mareninov S; Wadehra M; Zhang L; Goodglick L; Braun J; Gordon LK
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):462-9. PubMed ID: 18469192
[TBL] [Abstract][Full Text] [Related]
5. Functional consequences of interactions between FAK and epithelial membrane protein 2 (EMP2).
Morales SA; Mareninov S; Coulam P; Wadehra M; Goodglick L; Braun J; Gordon LK
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4949-56. PubMed ID: 19494199
[TBL] [Abstract][Full Text] [Related]
6. GBP5 drives malignancy of glioblastoma via the Src/ERK1/2/MMP3 pathway.
Yu X; Jin J; Zheng Y; Zhu H; Xu H; Ma J; Lan Q; Zhuang Z; Chen CC; Li M
Cell Death Dis; 2021 Feb; 12(2):203. PubMed ID: 33608513
[TBL] [Abstract][Full Text] [Related]
7. Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer.
Fu M; Maresh EL; Helguera GF; Kiyohara M; Qin Y; Ashki N; Daniels-Wells TR; Aziz N; Gordon LK; Braun J; Elshimali Y; Soslow RA; Penichet ML; Goodglick L; Wadehra M
Mol Cancer Ther; 2014 Apr; 13(4):902-15. PubMed ID: 24448822
[TBL] [Abstract][Full Text] [Related]
8. EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase.
Wang SD; Rath P; Lal B; Richard JP; Li Y; Goodwin CR; Laterra J; Xia S
Oncogene; 2012 Dec; 31(50):5132-43. PubMed ID: 22310282
[TBL] [Abstract][Full Text] [Related]
9. Epithelial membrane protein 2: Molecular interactions and clinical implications.
Chung LK; Bhatt NS; Lagman C; Pelargos PE; Qin Y; Gordon LK; Wadehra M; Yang I
J Clin Neurosci; 2017 Oct; 44():84-88. PubMed ID: 28720310
[TBL] [Abstract][Full Text] [Related]
10. Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model.
Sun MM; Chan AM; Law SM; Duarte S; Diaz-Aguilar D; Wadehra M; Gordon LK
Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):245-254. PubMed ID: 30646013
[TBL] [Abstract][Full Text] [Related]
11. Tissue microarray analysis for epithelial membrane protein-2 as a novel biomarker for gliomas.
Chung LK; Pelargos PE; Chan AM; Demos JV; Lagman C; Sheppard JP; Nguyen T; Chang YL; Hojat SA; Prins RM; Liau LM; Nghiemphu L; Lai A; Cloughesy TF; Yong WH; Gordon LK; Wadehra M; Yang I
Brain Tumor Pathol; 2018 Jan; 35(1):1-9. PubMed ID: 28887715
[TBL] [Abstract][Full Text] [Related]
12. MDA-9/syntenin is a key regulator of glioma pathogenesis.
Kegelman TP; Das SK; Hu B; Bacolod MD; Fuller CE; Menezes ME; Emdad L; Dasgupta S; Baldwin AS; Bruce JN; Dent P; Pellecchia M; Sarkar D; Fisher PB
Neuro Oncol; 2014 Jan; 16(1):50-61. PubMed ID: 24305713
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography imaging of endometrial cancer using engineered anti-EMP2 antibody fragments.
Fu M; Brewer S; Olafsen T; Wu AM; Gordon LK; Said J; Braun J; Wadehra M
Mol Imaging Biol; 2013 Feb; 15(1):68-78. PubMed ID: 22585360
[TBL] [Abstract][Full Text] [Related]
14. Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer.
Fu M; Maresh EL; Soslow RA; Alavi M; Mah V; Zhou Q; Iasonos A; Goodglick L; Gordon LK; Braun J; Wadehra M
Clin Cancer Res; 2010 Aug; 16(15):3954-63. PubMed ID: 20670949
[TBL] [Abstract][Full Text] [Related]
15. Epithelial membrane protein 2 controls VEGF expression in ARPE-19 cells.
Morales SA; Telander DG; Leon D; Forward K; Braun J; Wadehra M; Gordon LK
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2367-72. PubMed ID: 23439602
[TBL] [Abstract][Full Text] [Related]
16. Rewiring integrin-mediated signaling and cellular response with the peripheral myelin protein 22 and epithelial membrane protein 2 components of the tetraspan web.
Morales SA; Telander D; Notterpek L; Wadehra M; Braun J; Gordon LK
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5465-72. PubMed ID: 21421883
[TBL] [Abstract][Full Text] [Related]
17. The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma.
Li CF; Wu WJ; Wu WR; Liao YJ; Chen LR; Huang CN; Li CC; Li WM; Huang HY; Chen YL; Liang SS; Chow NH; Shiue YL
Oncotarget; 2015 Apr; 6(11):9220-39. PubMed ID: 25940704
[TBL] [Abstract][Full Text] [Related]
18. Anti-EMP2 diabody blocks epithelial membrane protein 2 (EMP2) and FAK mediated collagen gel contraction in ARPE-19 cells.
Morales SA; Telander DG; Mareninov S; Nagy A; Wadehra M; Braun J; Gordon LK
Exp Eye Res; 2012 Sep; 102():10-6. PubMed ID: 22728127
[TBL] [Abstract][Full Text] [Related]
19. Interference with PSMB4 Expression Exerts an Anti-Tumor Effect by Decreasing the Invasion and Proliferation of Human Glioblastoma Cells.
Cheng YC; Tsai WC; Sung YC; Chang HH; Chen Y
Cell Physiol Biochem; 2018; 45(2):819-831. PubMed ID: 29414809
[TBL] [Abstract][Full Text] [Related]
20. Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.
Lu KV; Zhu S; Cvrljevic A; Huang TT; Sarkaria S; Ahkavan D; Dang J; Dinca EB; Plaisier SB; Oderberg I; Lee Y; Chen Z; Caldwell JS; Xie Y; Loo JA; Seligson D; Chakravari A; Lee FY; Weinmann R; Cloughesy TF; Nelson SF; Bergers G; Graeber T; Furnari FB; James CD; Cavenee WK; Johns TG; Mischel PS
Cancer Res; 2009 Sep; 69(17):6889-98. PubMed ID: 19690143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]